Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S, Castelli G, Blaconà G, Bruno SM, Sette G, Pigliucci R, Villella VR, Esposito S, Zollo I, Spadaro F, Maria R, Biffoni M, Cimino G, Amato F, Lucarelli M, Eramo A. Lo Cicero S, et al. Among authors: eramo a. Respir Res. 2023 Sep 6;24(1):217. doi: 10.1186/s12931-023-02516-0. Respir Res. 2023. PMID: 37674160 Free PMC article.
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells.
Sette G, Lo Cicero S, Blaconà G, Pierandrei S, Bruno SM, Salvati V, Castelli G, Falchi M, Fabrizzi B, Cimino G, De Maria R, Biffoni M, Eramo A, Lucarelli M. Sette G, et al. Among authors: eramo a. Eur Respir J. 2021 Dec 2;58(6):2100908. doi: 10.1183/13993003.00908-2021. Print 2021 Dec. Eur Respir J. 2021. PMID: 34413153 Free PMC article.
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fbrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S, Castelli G, Blaconà G, Bruno SM, Sette G, Pigliucci R, Villella VR, Esposito S, Zollo I, Spadaro F, De Maria R, Biffoni M, Cimino G, Amato F, Lucarelli M, Eramo A. Lo Cicero S, et al. Among authors: eramo a. Respir Res. 2023 Sep 23;24(1):228. doi: 10.1186/s12931-023-02535-x. Respir Res. 2023. PMID: 37742000 Free PMC article. No abstract available.
Quantitative Evaluation of CFTR Gene Expression: A Comparison between Relative Quantification by Real-Time PCR and Absolute Quantification by Droplet Digital PCR.
Bruno SM, Blaconà G, Lo Cicero S, Castelli G, Virgulti M, Testino G, Pierandrei S, Fuso A, Cimino G, Ferraguti G, Eramo A, Lucarelli M. Bruno SM, et al. Among authors: eramo a. Genes (Basel). 2023 Sep 9;14(9):1781. doi: 10.3390/genes14091781. Genes (Basel). 2023. PMID: 37761921 Free PMC article.
Lung Cancer Organoids: The Rough Path to Personalized Medicine.
Rossi R, De Angelis ML, Xhelili E, Sette G, Eramo A, De Maria R, Cesta Incani U, Francescangeli F, Zeuner A. Rossi R, et al. Among authors: eramo a. Cancers (Basel). 2022 Jul 29;14(15):3703. doi: 10.3390/cancers14153703. Cancers (Basel). 2022. PMID: 35954367 Free PMC article. Review.
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.
Sette G, Fecchi K, Salvati V, Lotti F, Pilozzi E, Duranti E, Biffoni M, Pagliuca A, Martinetti D, Memeo L, Milella M, De Maria R, Eramo A. Sette G, et al. Among authors: eramo a. J Exp Clin Cancer Res. 2013 Nov 16;32(1):91. doi: 10.1186/1756-9966-32-91. J Exp Clin Cancer Res. 2013. PMID: 24238212 Free PMC article.
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
Sette G, Salvati V, Giordani I, Pilozzi E, Quacquarini D, Duranti E, De Nicola F, Pallocca M, Fanciulli M, Falchi M, Pallini R, De Maria R, Eramo A. Sette G, et al. Among authors: eramo a. Int J Cancer. 2018 Jul 1;143(1):88-99. doi: 10.1002/ijc.31260. Epub 2018 Jan 26. Int J Cancer. 2018. PMID: 29341112 Free article.
131 results